DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
SonoVue is an investigational drug.
There have been 33 clinical trials for SonoVue. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Neoplasms, and Coronary Artery Disease. The leading clinical trial sponsors are Bracco Diagnostics, Inc, University Hospital, Tours, and Catholic University of the Sacred Heart.
Recent Clinical Trials for SonoVue
|Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)||David Mooney||Phase 1/Phase 2|
|Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients||Chang Gung Memorial Hospital||N/A|
|Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients||NaviFUS Corporation||N/A|